Béatrice Lannes
Béatrice Lannes has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
Agathe Chammas
Hop Univ Strasbourg, Hop Hautepierre, Serv Imagerie 2, Strasbourg, France
1 shared publicationAlain Meyer
Alain Meyer, MD, PhD, Service de Physiologie et d'Explorations Fonctionnelles, Hôpitaux Universitaires de Strasbourg, Strasbourg, France
1 shared publication- Alain Meyer
UR 3072, “Mitochondria, Oxidative Stress and Muscle Plasticity”, Biomedicine Research Center of Strasbourg (CRBS), Faculty of Medicine, University of Strasbourg, 67000 Strasbourg, France
1 shared publication Aleksandra Nadaj Pakleza
Department of Neurology, National Reference Centre for Neuromuscular Diseases
1 shared publication- Andoni Echaniz‐Laguna
Neurology Department APHP, CHU de Bicêtre Le Kremlin‐Bicêtre France
1 shared publication - Anne Boland
Université Paris-Saclay, CEA, Centre National de Recherche en Génomique Humaine (CNRGH), Evry, France
1 shared publication
Latest Publications
- 2 October 2024
- Published by Elsevier in Annales de Pathologie
- Vol. 44 (6)
Angiopathie amyloïde cérébroméningée
- 2 October 2024
- Published by Elsevier in Annales de Pathologie
- Vol. 44 (6)
Angiopathie amyloïde cérébroméningée
- Open Access
- 15 October 2023
- Published by The Journal of Rheumatology in The Journal of Rheumatology
- Vol. 51 (2) , 207
Skeletal and Cardiac Muscle Hydroxychloroquine Toxicity
The prevalence of long-term antimalarial muscle and cardiac toxicity has been estimated at 6.5%.1 Antimalarial-induced cardiomyopathy is reversible in 45% of cases after treatment discontinuation and is associated with a 20% mortality rate.2
- 15 October 2023
- Published by The Journal of Rheumatology in The Journal of Rheumatology
- Vol. 51 (2) , 207
Open AccessSkeletal and Cardiac Muscle Hydroxychloroquine Toxicity
The prevalence of long-term antimalarial muscle and cardiac toxicity has been estimated at 6.5%.1 Antimalarial-induced cardiomyopathy is reversible in 45% of cases after treatment discontinuation and is associated with a 20% mortality rate.2
- Open Access
- 17 September 2021
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 61 (2) , e35-e37
Bilateral gastrocnemius myositis: an extra-intestinal manifestation of Crohn’s disease
- 17 September 2021
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 61 (2) , e35-e37
Open AccessBilateral gastrocnemius myositis: an extra-intestinal manifestation of Crohn’s disease
- 26 March 2018
- Published by SAGE Publications in Journal of Neuromuscular Diseases
- Vol. 5 (2) , 257-260
Novel SPEG Mutations in Congenital Myopathy without Centralized Nuclei
Congenital myopathies are clinically and genetically heterogeneous, and are classified based on typical structural abnormalities on muscle sections. Recessive mutations in the striated muscle preferentially expressed protein kinase ( SPEG) were recently reported in patients with centronuclear myopathy (CNM) associated in most cases with dilated cardiomyopathy. Here we report the identification of novel biallelic truncating SPEG mutations in a patient with moderate congenital myopathy without clinical and histological hallmarks of CNM and without cardiomyopathy. This study expands the phenotypic spectrum of SPEG-related myopathy and prompts to consider SPEG for congenital myopathies without specific histological features.
- 26 March 2018
- Published by SAGE Publications in Journal of Neuromuscular Diseases
- Vol. 5 (2) , 257-260
Novel SPEG Mutations in Congenital Myopathy without Centralized Nuclei
Congenital myopathies are clinically and genetically heterogeneous, and are classified based on typical structural abnormalities on muscle sections. Recessive mutations in the striated muscle preferentially expressed protein kinase ( SPEG) were recently reported in patients with centronuclear myopathy (CNM) associated in most cases with dilated cardiomyopathy. Here we report the identification of novel biallelic truncating SPEG mutations in a patient with moderate congenital myopathy without clinical and histological hallmarks of CNM and without cardiomyopathy. This study expands the phenotypic spectrum of SPEG-related myopathy and prompts to consider SPEG for congenital myopathies without specific histological features.
- 1 April 2012
- Published by Elsevier in Revue Neurologique
- Vol. 168, A17
Ataxie cérébelleuse récessive par mutation de POLG1 : à propos d’une famille
- 1 April 2012
- Published by Elsevier in Revue Neurologique
- Vol. 168, A17
Ataxie cérébelleuse récessive par mutation de POLG1 : à propos d’une famille